Does Rallies show 13F holders for ACIU?

Yes. Rallies tracks hedge fund and 13F ownership data for ACIU, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ACIU research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ACIU. It does not provide personalized investment advice.

ACIU (AC Immune SA) Stock Analysis - Hedge Fund Holdings

AC Immune SA (ACIU) is a publicly traded Healthcare sector company. As of May 21, 2026, ACIU trades at $2.95 with a market cap of $281.91M and a P/E ratio of 0.00. ACIU moved +2.13% today. Year to date, ACIU is -17.90%; over the trailing twelve months it is +65.14%. Its 52-week range spans $1.43 to $4.00. Analyst consensus is strong buy with an average price target of $10.00. Rallies surfaces ACIU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ACIU stock?

Hedge funds tracked by Rallies that own ACIU include Redmile Group. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AC Immune SA.

ACIU Key Metrics

Key financial metrics for ACIU
Metric	Value
Price	$2.95
Market Cap	$281.91M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$4.00
52-Week Low	$1.43
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Top Hedge Funds Holding ACIU

Redmile Group holds 1.03M shares of ACIU, changed -38.95% as of Dec 31, 2024.

Latest ACIU News

AC Immune CEO Andrea Pfeifer to retire after 23 years; Dr Martin Zügel interim CEO — May 12, 2026
AC Immune Initiates Final ABATE Cohort, Doses First NLRP3 Inhibitor Subjects — Apr 30, 2026
AC Immune Outpaces Medical Peers with 2.2% YTD Return and 8% Earnings Estimate Upgrade — Apr 10, 2026
AC Immune Secures CHF10M Upfront, Potential CHF1.7B Milestones in Lilly Tau Collaboration — Apr 7, 2026
AC Immune Posts Positive Phase 2 Parkinson’s Data, Starts Phase 1 NLRP3 Trial — Mar 13, 2026

Recent ACIU Insider Trades

Pfeifer Andrea sold 10.00K (~$27.93K) on May 15, 2026.
Pfeifer Andrea sold 10.00K (~$31.43K) on Apr 15, 2026.
Pfeifer Andrea sold 10.00K (~$31.43K) on Apr 15, 2026.

ACIU Analyst Consensus

3 analysts cover ACIU: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.00.

Common questions about ACIU

Who owns ACIU stock?: Hedge funds tracked by Rallies that own ACIU include Redmile Group. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AC Immune SA.
Does Rallies show 13F holders for ACIU?: Yes. Rallies tracks hedge fund and 13F ownership data for ACIU, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ACIU research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ACIU. It does not provide personalized investment advice.